DrugPatentWatch Database Preview
Laurus Labs Ltd Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for LAURUS LABS LTD, and what generic and branded alternatives to LAURUS LABS LTD drugs are available?
LAURUS LABS LTD has three approved drugs.
There are two tentative approvals on LAURUS LABS LTD drugs.
Summary for Laurus Labs Ltd
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
| Drug Master File Entries: | 44 |
| Patent Litigation for Laurus Labs Ltd: | See patent lawsuits for Laurus Labs Ltd |
Drugs and US Patents for Laurus Labs Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Laurus Labs Ltd | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 209882-002 | Aug 27, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Laurus Labs Ltd | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 209882-001 | Aug 27, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Laurus Labs Ltd | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 209882-003 | Aug 27, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Laurus Labs Ltd | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | emtricitabine; tenofovir disoproxil fumarate | TABLET;ORAL | 212114-001 | Jul 26, 2019 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
